A little help keeping your community in the loop. Good stories, good company.

Explore News.ggDiscord news bot World news for Discord Gaming news and patch notes RSS feeds for Discord Stock market alerts

Blog & GuidesNews.gg Blog Crypto News & Alerts Stock Market News Bots Gaming News Bots Setup Crypto Alerts Stocks Video Guide

ProductFeatures Dashboard Pricing Support

ResourcesBlog Help & Support Discord Server Twitter / X Changelog Developer API

CompanyCommunities Careers Log In Contact

LegalPrivacy Policy Terms of Service Cookie Policy

FDA is requiring weight loss drug makers to add a vision loss warning | News.gg

Wednesday, November 11, 2026Coverage from every side, on News.ggInternational Edition

News.gg

Home Latest Off the Radar

Subscribe Login

Published 2 days ago · Quartz · Updated 2 days ago

FDA is requiring weight loss drug makers to add a vision loss warning

Side-by-Side Framing

The warning covers all GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, over a rare eye condition called NAION

Summary from the original article

QuartzFactualityFactuality is a Premium featureHow reliably the outlets covering this story report facts, based on their track record of accuracy and corrections.Lean Left

Lean LeftBased on the outlet's overall lean; article framing check pending

The warning covers all GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, over a rare eye condition called NAION

By Cris Tolomia · Nov 9, 2026, 6:50 PM UTC

Read full article at Quartz

Side-by-Side Framing

Premium

AI key points, how left, center and right framed this story, tone by side and loaded language are part of News.gg Premium.

Upgrade this server

2 Articles

Hindustan TimesFactualityLean Left
Ozempic, Wegovy and other GLP-1 drugs to carry vision loss warning after FDA finds rare eye risk
US regulators say the rare eye condition NAION can cause permanent vision loss. All GLP-1 drugs, including Ozempic and Wegovy, will now carry the warning.
2 days ago · hindustantimes.com
QuartzFactualityLean Left
FDA is requiring weight loss drug makers to add a vision loss warning
The warning covers all GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, over a rare eye condition called NAION
2 days ago · qz.com · You are reading this one

Coverage Details

Total News Sources: 2
Leaning Left: 2
Leaning Right: 0
Center: 0
Last Updated: 2 days ago
Bias Distribution: 100% Left

Bias Distribution

• 100% of the sources are Left

L 100%

Hindustan TimesLean Left · hindustantimes.com

QuartzLean Left · qz.com

Factuality

To view factuality data please Upgrade to Premium

Timeline

Nov 9, 2026, 6:50 PM UTC · first report
Quartz FDA is requiring weight loss drug makers to add a vision loss warning
Nov 10, 2026, 5:51 AM UTC
Hindustan Times Ozempic, Wegovy and other GLP-1 drugs to carry vision loss warning after FDA finds rare eye risk

Bias ratings are News.gg assessments of each article's wording compared with other outlets covering the same story.

Sky News · 2 days ago

FDA orders blindness risk warning on weight loss drugs

100% Center coverage: 1 source

Yeniçağ · 2 days ago

FDA'den zayıflama iğnesi uyarısı: GLP-1 ilaçları görme kaybı riski taşıyor

100% Center coverage: 1 source

Karar Haber · 2 days ago

Ozempic ve Wegovy kullananlara FDA uyarısı: Görme kaybına dikkat!

100% Center coverage: 1 source